COL5A1在肺状细胞癌中的作用:预后影响和治疗潜力
Chengjuan Zhang1, Bo Wang2, Tingjie Wang2
1Center of Bio-Repository, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, Henan, China.
International immunopharmacology
|January 4, 2025
概括
原体V型α1 (COL5A1) 是肺状细胞癌 (LUSC) 进展中的关键分子. 抑制COL5A1可能为LUSC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺状细胞癌 (LUSC) 对晚期的治疗选择有限.
- 识别预后分子对于开发LUSC的向疗法至关重要.
研究的目的:
- 在LUSC中识别预后分子.
- 为已识别的分子的潜在治疗应用提供基础.
主要方法:
- 使用NanoString进行免疫相关的转录组分析.
- 预测转录学签名的开发和验证.
- 分子生物学实验,以评估免疫特性和细胞功能.
主要成果:
- 短期和长期生存组之间的免疫细胞群 (T细胞,B细胞) 显著差异.
- 在短期幸存者中激活PI3K-AKT,NF-kappaB和转移途径;在长期幸存者中激活DNA修复途径.
- 鉴定出作为预后标记物的V型原体α1 (COL5A1);COL5A1的敲除抑制了LUSC细胞的增殖和侵入.
结论:
- COL5A1在LUSC瘤进展中起着至关重要的作用.
- COL5A1 抑制剂显示出作为LUSC.治疗策略的前景.
更多相关视频
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
9.2K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
375
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
